Cromar Zachary J, Chen Ryan, Riesgo Tamara Juvier, Yan Denise, Verma Lindsay Dawn, Chen Zhengyi, Blanton Susan H, Lam Byron L, Liu Xue Zhong
Department of Human Genetics, Dr. John T. Macdonald Foundation, University of Miami Miller School of Medicine, Miami, USA.
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, USA.
Hum Genomics. 2025 Jun 18;19(1):68. doi: 10.1186/s40246-025-00775-0.
Usher syndrome (USH) is the leading genetic cause of congenital deaf blindness worldwide. USH is an autosomal recessive disorder clinically characterized by partial or complete congenital sensorineural hearing loss followed by progressive vision loss due to retinitis pigmentosa. There are three main subtypes (USH1, USH2, USH3) with different genetic causes categorized by age of symptom onset and severity. Understanding the genetic epidemiology of USH can help identify novel mutations and facilitate definitive diagnosis and treatment. This retrospective study characterizes the mutation spectrum of USH in an ethnically diverse South Florida population.
Of the 148 patients assessed for this study, 67 were male and 81 were female. In this population, one identified as American Indian or Alaska Native, 6 identified as Asian (A), eight identified as Black or African American (AA), eight identified as More than One Race, 26 were identified as Unknown or Not Reported, and 99 were identified as white. In addition, 42 identified as Hispanic or Latino, 87 identified as Non-Hispanic or Latino, and 19 were identified as Unknown or Not Reported; all individuals identifying as Hispanic or Latino were either White or Unknown. One American Indian or Alaska Native patient, two Asian patients, two Black or African American Patients, and 15 white patients had inconclusive molecular testing results. In our population, White Non-Hispanics were more likely to receive a conclusive molecular diagnosis for their hearing loss.
This is the first genetic characterization of an ethnically diverse South Florida population with USH, which can help direct patient diagnosis and medical care. As clinical trials for treatment increases, molecular testing in all individuals is imperative.
尤塞综合征(USH)是全球先天性聋哑失明的主要遗传病因。USH是一种常染色体隐性疾病,临床特征为部分或完全先天性感音神经性听力损失,随后因色素性视网膜炎导致进行性视力丧失。USH主要有三种亚型(USH1、USH2、USH3),根据症状出现的年龄和严重程度,其遗传病因各不相同。了解USH的遗传流行病学有助于识别新的突变,并促进明确的诊断和治疗。这项回顾性研究描述了南佛罗里达州一个种族多样化人群中USH的突变谱。
在本研究评估的148例患者中,67例为男性,81例为女性。在这个群体中,1人被认定为美洲印第安人或阿拉斯加原住民,6人被认定为亚洲人(A),8人被认定为黑人或非裔美国人(AA),8人被认定为多种族,26人被认定为未知或未报告,99人被认定为白人。此外,42人被认定为西班牙裔或拉丁裔,87人被认定为非西班牙裔或拉丁裔,19人被认定为未知或未报告;所有被认定为西班牙裔或拉丁裔的个体要么是白人,要么是未知。1例美洲印第安人或阿拉斯加原住民患者、2例亚洲患者、2例黑人或非裔美国患者以及15例白人患者的分子检测结果不明确。在我们的人群中,非西班牙裔白人更有可能因其听力损失获得明确的分子诊断。
这是对南佛罗里达州一个种族多样化的USH人群的首次基因特征描述,有助于指导患者诊断和医疗护理。随着治疗临床试验的增加,对所有个体进行分子检测势在必行。